Skip to content

4Accepted Aug 4, 4:11 PM ET

Imunon (IMNN) CMO Douglas Vincent Faller Receives 3,649-Share Award

IMNNImunon, Inc.

Accepted (ET)

4:11 PM

Aug 4, 2026

Filed

Aug 4, 2026

Documents

1

Size

4.8 KB

Summary

Imunon (IMNN) CMO Douglas Vincent Faller Receives 3,649-Share Award

Updated

What Happened
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), was granted 3,649 shares on July 31, 2026. The shares were valued at $1.59 each, for a total reported value of $5,802. This was an equity award (transaction code A) granted in lieu of a portion of his base salary.

Key Details

  • Transaction date: 2026-07-31; SEC filing date: 2026-08-04 (filed within the required period).
  • Transaction type/code: Award/Grant (A) — stock issued to the insider as compensation.
  • Shares granted: 3,649 at $1.59 per share; total value $5,802.
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Footnote: stock granted in lieu of cash for portion of base salary (compensation, not an open-market purchase).
  • No indication in the filing of a 10b5-1 plan, tax withholding, or late filing.

Context
This transaction is a compensation-related equity award, meaning the shares were issued as payment rather than bought on the open market. Compensation grants are common and reflect payroll/compensation mechanics more than immediate insider sentiment about the stock.

AI-written summary · check the filing